Alnylam Pharmaceuticals, Inc. (ALNY)
Analyst consensus, price target and coverage. 24 analysts, updated daily.
Analyst votes
How the ratings break down
27 ratings on record
- Strong Buy7
- Buy14
- Hold6
- Underperform0
- Sell0
Price targets
Where the estimates sit
How far apart analysts are on this name.
Low 230.00
Mean 375.76
High 536.00
share price 227.12 mean target 375.76. Analysts are spread 133% apart, and the share price sits below every target on record.
Most recent action
Last rating change
| Firm | Truist Securities |
|---|---|
| Date | 2026-08-04 |
| Change | Buy → Buy |
Size and liquidity
Key statistics
| Market cap | 30.39B USD |
|---|---|
| Cap class | Large |
| Average volume | 1,625,109 |
| Dollar volume per day | 369.1M |
| Liquidity | High |
| Internal score | 89.4 / 100 |
Recommendation
How it moved, scan by scan
3 scans on record
| Scan | Move | Consensus | Score | SB | Buy | Hold | Und | Sell |
|---|---|---|---|---|---|---|---|---|
| 2026-08-14 07:29 | = | Buy | 1.96 | 7 | 14 | 6 | 0 | 0 |
| 2026-08-13 | = | Buy | 1.96 | 7 | 14 | 6 | 0 | 0 |
| 2026-08-11 | · | Buy | 1.96 | 7 | 14 | 6 | 0 | 0 |
Score is the analyst average on Yahoo's scale, where 1 is Strong Buy and 5 is Sell, so a falling number means the view improved. ▲ more positive, ▼ more negative, = unchanged.
History
Price target over time
3 daily points recorded
| Date | Price | Target | Upside | Consensus |
|---|---|---|---|---|
| 2026-08-14 | 227.12 | 375.76 | +65.4% | Buy |
| 2026-08-13 | 223.95 | 375.76 | +67.8% | Buy |
| 2026-08-11 | 219.33 | 375.76 | +71.3% | Buy |
Similar coverage
Comparable large-cap names
Closest upside among companies of the same size.